🧫

Early disease phase characterized by remyelination response from oligodendrocyte precursor cells.

active
experiment Created: 2026-04-27T23:23:53 By: etl-v1-backfill Quality: 50% ✓ SciDEX ID: exp-57271b0bb15e
🧫 Experiment Protocol Cell BiologyAlzheimer's diseasehumanextracted
PRIMARY OUTCOME
Early disease phase characterized by remyelination response from oligodendrocyte precursor cells.
Source: pmid_39402379
🧫 Experiment Extras
PATHWAY
myelination
MARKET PRICE
$0.50
STATUS
extracted
Metadataorigin_type: v1_polymorphic_backfill
origin_typev1_polymorphic_backfill
source_tableexperiments
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.